Innovative treatment strategies for multiple myeloma Ruben Niesvizky, MD, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY, comments on new developments in treatments for multiple myeloma. Novel immunomodulating agents such as iberdomide and other cereblon E3 ligase modulators (CELMoDs) have shown promising results and could be given in combination with other immunological therapies. In […]

Read More